section name header

Pronunciation ⬇

mi-KON-a-zole

Classifications ⬆ ⬇

Therapeutic Classification: antifungals (oral, nonabsorbed)

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Affects the permeability of the fungal cell wall, allowing leakage of cellular contents.
Therapeutic effects:
  • Decrease in symptoms of oropharyngeal candidiasis.

Pharmacokinetics ⬆ ⬇

Absorption: Minimal systemic absorption.

Distribution: Inhibitory concentrations remain in saliva for up to 7 hr after buccal application of tablet.

Metabolism/Excretion: .

Half-Life: .

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
POunknownunknownup to 15 hr

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

GI: abnormal mouth sensations, diarrhea, dry mouth, dysgeusia, ↑liver function tests, nausea, vomiting

Derm: pruritis

Neuro: headache

Misc: ANAPHYLAXIS

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Lab Test Considerations:

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Oravig

Code ⬆

NDC Code